MORE►
Adults with Down syndrome
Photo: UNT Health Fort Worth
UNT Health FW Gets $6.8M for Alzheimer’s Study on Adults With Down Syndrome
by Sandra Engelland | May 28, 2026
Studies show the lifetime incidence of Alzheimer’s disease among adults with Down syndrome is 90%. Researchers called the national ABC-DS study "especially timely" as more treatment options for Alzheimer’s disease are found and more clinical trials are launched for adults with Down syndrome.
Related Articles
‘Shaping What’s Next’: Three Dallas Companies Win 2026 Edison Awards
French Researcher Joining UTSW Is Among Recipients of Up to $25M Cancer Grand Challenges Award
NASA Invests $750K in UTA Materials Research to Improve Advanced Air Mobility Safety
Fort Worth Hospital Ties Mayo Clinic as a Top U.S. Enrollment Site in Global Study of Life-Threatening Arrhythmias
TAMEST, Lyda Hill Philanthropies Announce 2026 Hill Prizes
MORE►
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Electric mobility is about more than battery range now. As EVs become part of everyday life, people want the experience to feel simple and reassuring, whether they are finding a charger, checking their vehicle status, making a payment, or getting help when they need it....
Plano-based Secretome Therapeutics, a biotech company advancing therapies derived from neonatal cardiac progenitor cells (nCPC), has announced the closing of $30 million in Series A financing from RA Capital Management, a multi-stage investment manager focused on public and private healthcare, life sciences, and planetary health companies....
“It’s critical that we increase awareness of the high prevalence of Alzheimer’s disease among adults with Down syndrome… ”
Melissa Petersen, Ph.D.
Associate Professor
UNT Health Fort Worth
.…on being UNT Health’s lead scientific investigator for the Alzheimer’s Biomarker Consortium-Down Syndrome (ABC-DS) study....
UNT Health Fort Worth’s Institute for Translational Research is set to become the first site in Texas to join a national study on Alzheimer’s disease in adults with Down syndrome.
The Alzheimer’s Biomarker Consortium-Down Syndrome (ABC-DS) study, a national research initiative supported by the National Institutes of Health, studies how Alzheimer’s disease develops in adults with Down syndrome and aims to identify early biological markers of the disease....
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Electric mobility is about more than battery range now. As EVs become part of everyday life, people want the experience to feel simple and reassuring, whether they are finding a charger, checking their vehicle status, making a payment, or getting help when they need it....
Plano-based Secretome Therapeutics, a biotech company advancing therapies derived from neonatal cardiac progenitor cells (nCPC), has announced the closing of $30 million in Series A financing from RA Capital Management, a multi-stage investment manager focused on public and private healthcare, life sciences, and planetary health companies....
“It’s critical that we increase awareness of the high prevalence of Alzheimer’s disease among adults with Down syndrome… ”
Melissa Petersen, Ph.D.
Associate Professor
UNT Health Fort Worth
.…on being UNT Health’s lead scientific investigator for the Alzheimer’s Biomarker Consortium-Down Syndrome (ABC-DS) study....
UNT Health Fort Worth’s Institute for Translational Research is set to become the first site in Texas to join a national study on Alzheimer’s disease in adults with Down syndrome.
The Alzheimer’s Biomarker Consortium-Down Syndrome (ABC-DS) study, a national research initiative supported by the National Institutes of Health, studies how Alzheimer’s disease develops in adults with Down syndrome and aims to identify early biological markers of the disease....
